Last reviewed · How we verify
NCT05289674: Interleukin
The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection
NA trial testing High Calorie Formula in Failure to Thrive in 75 participants. Completed in 30 June 2022.
30 June 2022
Quick facts
| Lead sponsor | Universitas Airlangga |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 75 |
| Start date | 4 October 2021 |
| Primary completion | 30 June 2022 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- High Calorie Formula
Conditions studied
- Failure to Thrive — all drugs for Failure to Thrive →
- Infections — all drugs for Infections →
Sponsor
Universitas Airlangga — full company profile →
Who can join
Adults 1 to 5, any sex, with Failure to Thrive or Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lactoferrin is an iron-binding glycoprotein of the transferrin family which is expressed and refers to it as a "red protein from milk". It is known that lactoferrin can modulate the overall immune response in inflammatory disorders including modulation of cytokine/ chemokine production and immune regulation that resenting by interleukin (IL)-10. Children with failure to thrive have increase the risk of infectious disease. The mechanism behind this may be due to impaired of immune function, in which pro-inflammation response is increased (IL-1β, IL-6), while IL-10 acted as anti-inflammation response tends to reduces. High calorie formula (Oral Nutrition Supplement/ONS) are products used for oral nutrition support with the aim of increasing nutritional intake. they are a nutrition treatment option for when nutrition support has been identified beside dietary counselling. ONS are typically used in addition to a normal diet, when diet alone is insufficient to meet daily nutritional requirement due to infection or others. ONS should be treated like medication, ensure they are labelled with the patient's name and provided at the prescribed time. It is well established that nutritional deficiency or inadequate can impair immune function. Growing evidence suggest that for certain nutrients increased intake above currently recommended levels may help optimize immune function including improving the defense function and thus resistance to infection while maintaining tolerance. This study aims to analize the levels of IL-6 and IL- 10 in children with failure to thrive with infection before and after receiving the intervention of lactoferrin in high-calorie formula milk. This study is an observational study with a pre-, post-test design, with designed total subject is 80. The subject is healthy children with weight faltering aged 1-5 years diagnosed with infection (tuberculosis/TB or urinary tract infection/UTI)
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effect of lactoferrin in oral nutrition supplement (ONS) towards IL-6 and IL-10 in failure to thrive children with infection.
Widjaja NA, Hamidah A, Purnomo MT, Ardianah E. · · 2023 · cited 4× · PMID 38434639 · DOI 10.12688/f1000research.130176.3 -
Effect of lactoferrin in oral nutrition supplement (ONS) towards IL-6 and IL-10 in failure to thrive children with infection
Widjaja NA, Hamidah A, Purnomo MT, Ardianah E. · · 2023 · DOI 10.12688/f1000research.130176.3
Verify or expand the search:
- PubMed search for NCT05289674
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universitas Airlangga trials
Trials by the same sponsor.
- NCT07418762 — Community-Based Program Integrating Nurse-Led Mind-Body Exercise and Nutrition for Frailty · NA · not yet recruiting
- NCT07265856 — The Effect of a Comprehensive Dementia Education Program on Improving Attitudes Toward People Living With Dementia · NA · enrolling by invitation
- NCT07238439 — Scenario-Driven Virtual Reality Game for Dementia Education Program · NA · enrolling by invitation
- NCT06629844 — Enhancing Healthcare Students' Attitudes Toward Dementia Care Through Virtual Reality Education · NA · completed
- NCT06160765 — The Efficacy of High Density Formula 1.5 kcal/ml or 1 kcal/ml On Catch Up Growth In Growth Faltering Children · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05289674 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitas Airlangga
- Last refreshed: 4 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05289674.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing